Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy
AffiliationDivision of Cancer Sciences, School of Medical Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Mancheste
MetadataShow full item record
AbstractPurpose: 4D-CT is routine imaging for lung cancer patients treated with stereotactic body radiotherapy. No studies have investigated optimal 4D phase selection for radiomics. We aim to determine how phase data should be used to identify prognostic biomarkers for distant failure, and test whether stability assessment is required. A phase selection approach will be developed to aid studies with different 4D protocols, and account for patient differences. Methods: 186 features were extracted from the tumour and peritumour on all phases for 258 patients. Feature values were selected from phase features using four methods: A) mean across phases, B) median across phases, C) 50% phase, and D) the most stable phase (closest in value to two neighbours), coined personalised selection. Four levels of stability assessment were also analysed, with inclusion of: 1) all features, 2) stable features across all phases, 3) stable features across phase and neighbour phases, and 4) features averaged over neighbour phases. Clinical-radiomics models were built for twelve combinations of feature type and assessment method. Model performance was assessed by concordance index and fraction of new information from radiomic features. Results: The most stable phase spanned the whole range but was most often near exhale. All radiomic signatures provided new information for distant failure prediction. The personalised model had the highest concordance index (0.77), and 58% of new information was provided by radiomic features when no stability assessment was performed. Conclusion: The most stable phase varies per-patient and selecting this improves model performance compared to standard methods. We advise the single most stable phase should be determined by minimising feature differences to neighbour phases. Stability assessment over all phases decreases performance by excessively removing features. Instead, averaging of neighbour phases should be used when stability is of concern. The models suggest that higher peritumoural intensity predicts distant failure.
CitationDavey A, van Herk M, Faivre-Finn C, Brown S, McWilliam A. Optimising use of 4D-CT phase information for radiomics analysis in lung cancer patients treated with stereotactic body radiotherapy. Phys Med Biol. 2021 Apr 21
JournalPhysics in Medicine and Biology
- Radiomic feature stability across 4D respiratory phases and its impact on lung tumor prognosis prediction.
- Authors: Du Q, Baine M, Bavitz K, McAllister J, Liang X, Yu H, Ryckman J, Yu L, Jiang H, Zhou S, Zhang C, Zheng D
- Issue date: 2019
- Application and limitation of radiomics approach to prognostic prediction for lung stereotactic body radiotherapy using breath-hold CT images with random survival forest: A multi-institutional study.
- Authors: Kakino R, Nakamura M, Mitsuyoshi T, Shintani T, Kokubo M, Negoro Y, Fushiki M, Ogura M, Itasaka S, Yamauchi C, Otsu S, Sakamoto T, Sakamoto M, Araki N, Hirashima H, Adachi T, Matsuo Y, Mizowaki T
- Issue date: 2020 Sep
- Interchangeability of radiomic features between [18F]-FDG PET/CT and [18F]-FDG PET/MR.
- Authors: Vuong D, Tanadini-Lang S, Huellner MW, Veit-Haibach P, Unkelbach J, Andratschke N, Kraft J, Guckenberger M, Bogowicz M
- Issue date: 2019 Apr
- Investigation of thoracic four-dimensional CT-based dimension reduction technique for extracting the robust radiomic features.
- Authors: Tanaka S, Kadoya N, Kajikawa T, Matsuda S, Dobashi S, Takeda K, Jingu K
- Issue date: 2019 Feb
- CT-based radiomic analysis of stereotactic body radiation therapy patients with lung cancer.
- Authors: Huynh E, Coroller TP, Narayan V, Agrawal V, Hou Y, Romano J, Franco I, Mak RH, Aerts HJ
- Issue date: 2016 Aug